Skip to Content
Merck
CN

The design and synthesis of sulfonamides as caspase-1 inhibitors.

Bioorganic & medicinal chemistry letters (2004-01-27)
William G Harter, Hans Albrect, Kenneth Brady, Bradley Caprathe, James Dunbar, John Gilmore, Sheryl Hays, Catherine R Kostlan, Beth Lunney, Nigel Walker
ABSTRACT

A series of sulfonamides (1) has been prepared as inhibitors of interleukin-1beta converting enzyme (ICE), also known as caspase 1. These compounds were designed to improve potency by rigidifying the enzyme bound molecule through an intramolecular hydrogen bond. An X-ray crystal structure of a representative member of this series bound to the active site of ICE, confirms the presence of the hydrogen bonding interaction.